This study investigated whether the interaction between isolates of Candida albicans (n = 7), Candida parapsilosis (n = 3), Candida krusei (n = 2), Candida dubliniensis (n = 1) and sertraline, a typical selective serotonin reuptake inhibitor, alters candidal virulence. Sertraline treatment of Candida spp. significantly (P 6 0.05) affected hyphal elongation, phospholipase activity, production of secreted aspartyl proteinases and fungal viability. In addition, monocyte-derived macrophages (MDMs) treated with sertraline reduced inhibition of blastoconidia germination in comparison to MDMs alone. In conclusion, our findings suggest that the interaction between sertraline and Candida spp. may also diminish the virulence properties of this fungal pathogen in vivo.
Introduction
Years ago antimicrobial activity was reported for psychotropic drugs of the Phenothiazine and Thioxanthene groups [1] . Since then, several non-antibacterial substances have been examined, and it was reported that selective serotonin reuptake inhibitors (SSRIs) in£uence the in vitro viability of bacteria [2, 3] and may reverse chloroquine resistance in Plasmodium falciparum [4] . These drugs exert a signi¢cant antimicrobial activity, mainly against Grampositive bacteria, yet are inactive against most enterobacteria [3] .
SSRIs are increasingly being used as ¢rst-line therapy for severe premenstrual syndrome (PMS) and as antidepressants [5] . In humans, SSRIs modify the behavior of 5-hydroxytryptamine (5-HT) in the synapse space. These antidepressants act primarily on the 5-HT transporter protein (SERT) and block the reuptake process of 5-HT. SERTs, with molecular masses of 60^80 kDa and 12 transmembrane domains, are similar to other biogenic amine transporters and sodium-and chloride-dependent transporters [6] .
Recently, we found that several SSRIs also exert fungicidal e¡ects against Aspergillus spp., conidia and hyphae [7] and that sertraline (SSRI, Tresleen 0 , Vienna, Austria) showed in vivo and in vitro antifungal activity against Candida spp. [8] .
The present study investigated whether the interaction between sertraline and Candida spp. directly a¡ects the virulence properties of this fungal pathogen in vitro.
Materials and methods

Candida spp. cultivation
Candida albicans CBS 5982 (Centraal Bureau voor Schimmelcultures, Baarn, The Netherlands) and clinical isolates of C. albicans (n = 7), Candida parapsilosis (n = 3), Candida krusei (n = 2) and Candida dubliniensis (n = 1) were used in this study. The strains were initially grown on Sabouraud dextrose agar (Oxoid, Basingstoke, UK) at 37 ‡C for 72 h. Cell culture £asks (Becton Dickinson, Lin-coln Park, NJ, USA) were inoculated at an initial concentration of 1U10 6 yeast cells ml 31 and incubated for 20 h at 30 ‡C if not indicated otherwise.
Drug
Sertraline HCl (molecular weight 343 kDa) was kindly provided by P¢zer (Global Research and Development, Groton, CT, USA). The stock solution was prepared following the manufacturer's instructions: sertraline powder was dissolved in sterile aqua ad injectionem (Fresenius, Linz, Austria) at room temperature for 30 min and centrifuged. Serial two-fold drug dilutions from 950 Wg ml 31 to 0.37 Wg ml 31 were prepared and concentrations from 475 Wg ml 31 to 0.18 Wg ml 31 were used for in vitro tests.
Hyphal elongation
The morphology of isolates of C. albicans (n = 7), C. parapsilosis (n = 3), C. krusei (n = 2) and C. dubliniensis (n = 1) treated with or without sertraline was investigated by assessing hyphal elongation [9] . Therefore, 2U10
5 yeast cells ml 31 of RPMI 1640 were inoculated into microwell plates (Greiner, Kremsmu « nster, Austria) and incubated at 37 ‡C. The morphology of the organisms was determined microscopically at the times indicated; a micrometer was used for length measurement. Each sample was assessed in triplicate, measuring 50 organisms per sample.
Determination of extracellular phospholipase activity
The extracellular phospholipase activity of C. albicans (n = 7) was measured using the egg yolk agar method [9] . Brie£y, the egg yolk agar consisted of Sabouraud Dextrose Agar (SDA) (in 184 ml of distilled water), 13.0 g; NaCl, 11.7 g; CaCl 2 , 0.111 g; and 10% sterile egg yolk and was poured into 60 mm diameter Petri dishes (Becton Dickinson). C. albicans strains were plated at a concentration of 1U10 7 yeast cells ml 31 in aliquots of 10 Wl onto egg yolk agar. After incubation of the agar at 37 ‡C for 72 h, the diameter of the precipitation zone around the colonies was determined. C. albicans and C. dubliniensis (2U10 6 colony-forming units (CFU) ml 31 ) were incubated in 1 ml of Sap induction medium (pH 4.0) consisting of 1% bovine serum albumin (BSA, fraction V, Sigma, St. Louis, MO, USA), 2% glucose, 0.1% KH 2 PO 4 , 0.05% MgSO 4 and 1% 100Umi-nimum essential medium vitamins (Sigma). Every other day various amounts of sertraline (237 to 0.25 Wg ml 31 ) or phosphate-bu¡ered saline (PBS) were added. After growth in this medium at 20 ‡C for 7 days under continuous rotation, colony-forming units were counted and Sap activity was assessed using a modi¢ed version of the original protocol by Ollert et al. [10] . Brie£y, the suspension was centrifuged at 3500Ug for 10 min. The amount of proteinase antigen in the supernatant was determined by absorbing aliquots of the supernatant to microwell plates (Greiner, Kremsmu « nster, Austria). Antigen detection was accomplished using the monoclonal mouse IgG antibody FX 7 31 0 (2 Wg ml 31 ) (kindly provided by Dr. Borg-von Zeppelin, Go « ttingen, Germany), which reacts with an epitope of Sap2.
Germination assay
The ability of macrophages to inhibit germination of blastoconidia of C. albicans (n = 7), C. parapsilosis (n = 3) and C. krusei (n = 2) was determined using a modi¢cation of Waldorf et al. [11] . After di¡erentiation of human monocytes to monocyte-derived macrophages (MDMs) in 24-well plates according to a method of Kacani et al. [12] , non-adherent cells were discarded by washing with RPMI 1640. Sertraline was added to each well at di¡erent concentrations. The macrophages were challenged with blastoconidia at a ratio of 1:1 and centrifuged for 5 min at 100Ug to facilitate contact between blastoconidia and e¡ector cells. Incubation was continued for a total of 4 h at 37 ‡C in a CO 2 incubator, after which the plates were centrifuged, the supernatants discarded and 0.5 ml of 2.5% deoxycholate (Sigma, Vienna, Austria) was added to each well to lyse macrophages. The plates were stained with lactophenol cotton blue (Merck, Vienna, Austria), and an inverted microscope was used to visualize germination of blastoconidia. The inhibition rate was calculated from the percentage of blastoconidia which did not germinate out of a total of 100 examined per well.
Statistics
Statistical signi¢cance was determined using the Student's t-test analysis. All comparisons were two-sided, and P 6 0.05 was considered signi¢cant.
Results
C. albicans and non-C. albicans morphology after treatment with sertraline
Signi¢cant di¡erences in hyphal elongation were observed for Candida spp. treated with sertraline as compared to untreated yeasts (Table 1) .
E¡ect of sertraline on the activity of extracellular
phospholipases of several C. albicans Treatment with sertraline signi¢cantly decreased phospholipase activity as compared to control (Table 2 ).
3.3. E¡ect of sertraline on production of Candida-secreted aspartyl proteinases (Saps)
Growth of Candida was signi¢cantly impaired at 237 Wg ml 31 sertraline (Fig. 1A , black columns) and Sap production was clearly and signi¢cantly impaired at 7 and 118 Wg ml 31 (Fig. 1A , white columns), concentrations which do not have an e¡ect on fungal growth. The maximum Sap reduction at low sertraline concentrations which did not a¡ect the growth of Candida was s 80% Sap reduction at 118 Wg ml 31 sertraline. Similar data were observed for C. dubliniensis as shown in Fig. 1B .
In order to investigate whether the decrease in Sap concentration is due to a direct impact on Saps or an inhibition of production, sertraline was added at di¡erent concentrations to the supernatants of the positive control, which had been grown in induction medium for 7 days. After further 16 h at 20 ‡C, Sap activity was not found to be decreased at 7 Wg ml 31 (Fig. 2) , a concentration at which a signi¢cantly lower Sap production was recorded after 7 days coculture (Fig. 1) . At 118 and 237 Wg ml 31 the decrease in Sap production over 7 days was s 80 and s 90%, respectively, but the direct impact assessed by overnight culture was only approximately 20 or 50%, respectively (Fig. 2) . Thus, the sertraline concentrations required to inhibit Saps are about one magnitude lower than those needed to inhibit fungal growth, and most of the inhibition is due to an inhibition of production and only partly to a direct impact.
Inhibition assay
MDMs cultured in medium alone (control) inhibited germination of blastoconidia of C. albicans at (mean þ S.D.) 39 þ 7%, of C. parapsilosis at 37 þ 3% and of C. krusei at 41 þ 5%. Addition of 7 Wg ml 31 sertraline to C. albicans isolates led to a statistically signi¢cant increase in inhibition in comparison to the control (P 6 0.05, Table 3 ). Similar data were found for non-C. albicans strains: signi¢cant inhibition of blastoconidia for C. parapsilosis and C. krusei was at 7 and 14 Wg ml 31 sertraline, respectively.
Discussion
The present study shows that the direct interaction between sertraline and C. albicans and non-C. albicans isolates signi¢cantly a¡ects fungal virulence properties. Table 1 E¡ect of sertraline on growth of C. albicans (n = 7) and non-C. albicans (n = 5) isolates In all samples with s 1.5 Wg ml 31 sertraline blastoconidia were also detected. *P 6 0.05 in comparison to control. Values are means þ S.D. of three experiments, done in duplicate. Table 2 Phospholipase activity of C. albicans (n = 7) treated with sertraline The morphology of several Candida spp. was strongly altered since hyphal elongation was signi¢cantly decreased by sertraline. The lack of hyphal transformation for the various isolates of Candida spp. was observed at sertraline concentrations between 0.35 and 0.75 Wg ml 31 , which are close to tissue concentrations : the maximal achievable sertraline concentrations in vivo range between 0.05 and 2 Wg ml 31 [13] . The ability of C. albicans to undergo morphologic changes is an important virulence factor [14] . Therefore, it is likely that the inhibition of hyphal elongation is responsible for the favorable in vivo outcome during sertraline intervention in patients with recurrent vulvovaginal candidiasis [8] . It is widely recognized that formation of hyphae enhances adherence and tissue invasion, with more e⁄cient release of proteolytic enzymes. Isoforms of Saps, which are encoded by at least 10 related Sap genes, are involved in adherence and thus represent major virulence factors of the opportunistic yeast C. albicans [15] . The majority of Sap proteins is secreted by those C. albicans cells that directly adhere to the epithelial surface [16] , and a dominant Sap isoenzyme in vitro and possibly also in vivo is Sap2 [10, 15] , which is the predominant isoenzyme investigated here.
In addition to being fungicidal at higher concentrations, sertraline also exerts an inhibitory e¡ect on yeasts by inhibiting Sap (at least Sap2) release, even at concentrations which are a magnitude lower. The mechanism by which sertraline acts on the biology of fungi is not yet known. It is probable that antifungal activity results from an interaction of sertraline with fungal membrane transporter systems [7] .
Furthermore, extracellular phospholipase activity, which has been shown to be predictive for mortality in a murine mouse model of disseminated candidiasis, was also a¡ected by treatment of Candida with sertraline, at yet higher concentrations.
So far, innate and humoral immunity and cell-mediated immunity are all involved in host defense against C. albicans infection [17] . Although the contribution of each appears to be site-speci¢c, innate immunity by polymorphonuclear neutrophils and macrophages dominates protection against systemic candidiasis. In the presence of sertraline, the inhibition of blastoconidia germination was superior by MDMs to that of MDMs alone. One explanation could be a drug-induced enhancement of oxi- dative burst [18] , another may lie in the intracellular activity of sertraline. This drug is probably internalized with inoculum and exerts an e¡ect similar to that seen in the extracellular £uid.
In conclusion, our ¢ndings show that sertraline treatment of Candida spp. signi¢cantly (P 6 0.05) a¡ected hyphal elongation, phospholipase activity, production of secreted aspartyl proteinases, viability of the fungus and the alteration of host cells in vitro. These data probably re£ect a direct impact of sertraline on release or expression of virulence factors since fungicidal e¡ects were observed at higher concentrations. So far, the e¡ects observed and the presence of an increased concentration of 5-hydroxytryptamine, which also a¡ects fungal viability [19] , during sertraline treatment may ¢nally diminish the virulence of Candida spp. in vivo.
